PhageLab recently published a study in Scientific Reports (Nature Portfolio) that, for the first time, validates strain-level prediction of bacteria-phage interactions using machine learning and artificial intelligence models. This work represents a major milestone by demonstrating that complex biological interactions can be reliably anticipated with high reliability prior to validation in real-world systems.
The study reports predictive accuracies ranging from 78 to 94%, addressing one of the most persistent limitations in the applied use of bacteriophages: the lack of predictability beyond controlled laboratory conditions. These results provide strong evidence that PhageLab’s predictive platform enables a shift from trial-and-error experimentation toward a reliable, scalable, and actionable biology model.
The findings show that the platform maintains accuracy under real production conditions, enabling the selection of specific phages prior to deployment. Today, this technology is operating at industrial scale, supporting one of the largest deployments of bacteriophage-based solutions in animal health.
In a context defined by the advance of antimicrobial resistance, this research positions predictive biology as a practical and scalable pathway for the developing of next-generation biological alternatives. Moreover, it establishes a conceptual and technological foundation for future applications in human health and precisión medicine, where biological predictability is expected to become a structural requirement rather that a competitive advantage.
